Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ketone doai
Reexamination Certificate
2011-07-26
2011-07-26
Witherspoon, Sikarl (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ketone doai
C514S238800, C514S551000
Reexamination Certificate
active
07985776
ABSTRACT:
A method of delivering a curcuminoid to a patient, which includes iontophoretically delivering a charged curcuminoid across the skin of an Alzheimer's Disease patient.
REFERENCES:
patent: 2955898 (1960-10-01), Bailey
patent: 4105034 (1978-08-01), Shalaby
patent: 4130639 (1978-12-01), Shalaby
patent: 4140678 (1979-02-01), Shalaby
patent: 4141087 (1979-02-01), Shalaby
patent: 4205399 (1980-06-01), Shalaby
patent: 4208511 (1980-06-01), Shalaby
patent: 4482722 (1984-11-01), Thorbek
patent: 4529556 (1985-07-01), Bruza
patent: 5073641 (1991-12-01), Bundgaard
patent: 5334315 (1994-08-01), Matkovich
patent: 5401777 (1995-03-01), Ammon
patent: 5462667 (1995-10-01), Wollinsky
patent: 5464929 (1995-11-01), Bezwada
patent: 5595751 (1997-01-01), Bezwada
patent: 5597579 (1997-01-01), Bezwada
patent: 5607687 (1997-03-01), Bezwada
patent: 5618552 (1997-04-01), Bezwada
patent: 5620698 (1997-04-01), Bezwada
patent: 5622944 (1997-04-01), Hale
patent: 5645850 (1997-07-01), Bezwada
patent: 5648088 (1997-07-01), Bezwada
patent: 5679864 (1997-10-01), Krackov
patent: 5698213 (1997-12-01), Jamiolkowski
patent: 5700583 (1997-12-01), Jamiolkowski
patent: 5859150 (1999-01-01), Jamiolkowski
patent: 5876714 (1999-03-01), Nishikawa
patent: 5891924 (1999-04-01), Aggarwal
patent: 5980480 (1999-11-01), Rubenstein
patent: 5980481 (1999-11-01), Gorsuch
patent: 6096740 (2000-08-01), Mechoulam
patent: 6187332 (2001-02-01), Gern
patent: 6234991 (2001-05-01), Gorsuch
patent: 6482866 (2002-11-01), Dahayanaka
patent: 6489308 (2002-12-01), Shapiro
patent: 6500213 (2002-12-01), Braun
patent: 6656227 (2003-12-01), Levin
patent: 6790979 (2004-09-01), Lee et al.
patent: 6831108 (2004-12-01), Dahanayake
patent: 6866856 (2005-03-01), Lu
patent: 6884783 (2005-04-01), Jia
patent: 6900356 (2005-05-01), Gokaraju
patent: 7025742 (2006-04-01), Rubenstein
patent: 7205011 (2007-04-01), Chen et al.
patent: 7351745 (2008-04-01), Dryer
patent: 7416559 (2008-08-01), Shalaby
patent: 7462459 (2008-12-01), Zerangue
patent: 7582068 (2009-09-01), Koullick
patent: 2001/0051184 (2001-12-01), Heng
patent: 2002/0019382 (2002-02-01), Snyder
patent: 2003/0108628 (2003-06-01), Babish
patent: 2003/0147979 (2003-08-01), Mae
patent: 2003/0153512 (2003-08-01), Hergenhahn
patent: 2003/0157155 (2003-08-01), Lipp
patent: 2003/0199594 (2003-10-01), Shah
patent: 2004/0127470 (2004-07-01), Masferrer
patent: 2004/0127556 (2004-07-01), Lu
patent: 2004/0220113 (2004-11-01), Shapiro
patent: 2004/0220239 (2004-11-01), Shapiro
patent: 2004/0220242 (2004-11-01), Shapiro
patent: 2004/0220510 (2004-11-01), Koullick
patent: 2005/0020945 (2005-01-01), Tosaya
patent: 2005/0031651 (2005-02-01), Gervais
patent: 2005/0038371 (2005-02-01), Reich
patent: 2005/0164957 (2005-07-01), Jia
patent: 2005/0169960 (2005-08-01), Hunter
patent: 2005/0169961 (2005-08-01), Hunter
patent: 2005/0181005 (2005-08-01), Hunter
patent: 2005/0181009 (2005-08-01), Hunter
patent: 2005/0181036 (2005-08-01), Aggarwal
patent: 2005/0187140 (2005-08-01), Hunter
patent: 2005/0267221 (2005-12-01), Wellen
patent: 2006/0020329 (2006-01-01), Raze
patent: 2006/0067998 (2006-03-01), Kurzrock et al.
patent: 2006/0116757 (2006-06-01), Lashinski
patent: 2006/0134059 (2006-06-01), Dryer
patent: 2006/0134155 (2006-06-01), Dryer
patent: 2006/0134231 (2006-06-01), Hines
patent: 2006/0195142 (2006-08-01), Shalaby
patent: 2006/0224234 (2006-10-01), Jayaraman
patent: 2006/0240007 (2006-10-01), Sanders
patent: 2006/0264423 (2006-11-01), Wood
patent: 2006/0264497 (2006-11-01), Zeligs
patent: 2007/0010435 (2007-01-01), Frangione
patent: 2007/0060644 (2007-03-01), Vander Jagt
patent: 2007/0134305 (2007-06-01), Zilberman
patent: 2007/0224671 (2007-09-01), Shapiro
patent: 2007/0243132 (2007-10-01), Russell Jones
patent: 2007/0281045 (2007-12-01), Tripp
patent: 2008/0051691 (2008-02-01), Dragoon
patent: 2008/0075671 (2008-03-01), DiMauro
patent: 2008/0076821 (2008-03-01), DiMauro
patent: 2008/0082036 (2008-04-01), Trescony
patent: 2008/0090897 (2008-04-01), Steiner
patent: 2008/0153912 (2008-06-01), Dryer
patent: 2008/0160109 (2008-07-01), Dryer
patent: 2008/0175895 (2008-07-01), Kogure
patent: 2008/0213404 (2008-09-01), Johnson
patent: 2008/0241352 (2008-10-01), Shalaby
patent: 2008/0247987 (2008-10-01), Liggins
patent: 2008/0275016 (2008-11-01), Arbiser
patent: 2009/0047371 (2009-02-01), Turini
patent: 2009/0087385 (2009-04-01), Di Mauro
patent: 2009/0131850 (2009-05-01), Geiger
patent: 2009/0326275 (2009-12-01), DiMauro
patent: 2010/0087527 (2010-04-01), Dimauro
patent: 2010/0292512 (2010-11-01), Dimauro
patent: 1312106 (2003-03-01), None
patent: 1970548 (2008-11-01), None
patent: 504263 (1992-09-01), None
patent: 2000236843 (2000-09-01), None
patent: WO 9008128 (1990-07-01), None
patent: WO 9518606 (1995-07-01), None
patent: WO 0140188 (2001-06-01), None
patent: WO 2004014843 (2004-02-01), None
patent: WO 2008051474 (2008-05-01), None
patent: WO 2008131059 (2008-10-01), None
patent: WO 2009073050 (2009-06-01), None
patent: WO 2009073050 (2009-10-01), None
Yang et al. Curcumin Inhibits Formation of Amyloid B Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo. The Journal of Biological Chemistry, 2005, vol. 280 (7), pp. 5892-5901.
Valiveti et al. Intranasal absorbtion of Delta-9-tetrahydrocannabinol and WIN55,212-2 mesylate in rats. European Journal of Pharmaceutics and Biopharmaceutics, 2007, vol. 65, pp. 247-252.
Park et al. Journal of Natural Products, Sep. 2002, vol. 65 (9), pp. 1227 to 1231.
Praveen Tyle. Iontophoretic Devices for Drug Delivery. Pharmaceutical Research, 1986, vol. 3 (6), 318-326.
Office Action mailed Jun. 10, 2009 in pending U.S. Appl. No. 11/534,384.
Response filed by applicant on Sep. 10, 2009 in pending U.S. Appl. No. 11/534,384.
Final Office Action mailed Dec. 24, 2009 in pending U.S. Appl. No. 11/534,384.
Office Action mailed Sep. 17, 2009 in pending U.S. Appl. No. 11/736,278.
Response filed by applicant on Sep. 25, 2009 in pending U.S. Appl. No. 11/736,278.
Final Office Action mailed Dec. 3, 2009 in pending U.S. Appl. No. 11/736,278.
Response filed by applicant on Mar. 3, 2010 in pending U.S. Appl. No. 11/736,278.
Office Action mailed Dec. 17, 2009 in Pending U.S. Appl. No. 12/029,904.
Office Action mailed Sep. 2, 2009 in pending U.S. Appl. No. 12/343,750.
Response filed by applicant on Dec. 2, 2009 in pending U.S. Appl. No. 12/343,750.
Pending Non-Published U.S. Appl. No. 12/359,713, filed Jan. 26, 2009 entitled Methylene Blue-Curcumin Analog for the Treatment of Alzheimer's Disease.
International Search Report dated Jul. 14, 2008 PCT/US08/60569.
International Search Report dated Aug. 27, 2009 PCT/US09/48466.
Pending Non-Published U.S. Appl. No. 12/571,303, filed Sep. 30, 2009 entitled Curcumin Derivatives.
Pending Non-Published U.S. Appl. No. 12/696,588, filed Jan. 29, 2010 entitled Shunt Delivery of Curcumin.
Pending Non-Published U.S. Appl. No. 12/697,503, filed Feb. 1, 2010 entitled Methylene Blue-Curcumin Analog for the Treatment of Alzheimer's Disease.
Abla, “Effect of Charge and Molecular Weight on Transdermal Peptide Delivery of Iontophoresis”;Pharm. Res; Dec. 2005; pp. 2069-2078; vol. 22(12).
Alas, “Inhibition of Constitutive STAT3 Activity Sensitizes Resistant Non-Hodgkin's Lymphoma and Multiple Myeloma to Chemotherapeutic Drug-Mediated Apoptosis”;Clin. Cancer Res.; Jan. 2003; pp. 316-326; vol. 9(1).
Al-Ghananeem, “Targeted Brain Delivery of 17β-Estradiol Via Nasally Administered Water Soluble Prodrugs”;AAPS PharmSciTech; 2002; pp. 1-8; vol. 3(1); article 5.
Allcock, “Polyphosphazenes”;The Encyclopedia of Polymer Science; 1988; pp. 31-41; vol. 13; Wiley Intersciences, John Wiley & Sons.
Altomare, “Highly Water-soluble Derivatives of the Anesthetic Agent Propofol: in vitro and in vivo Evaluation of Cyclic Amino Acid Esters”;Eur. J. Pharm. Sci.; 2003; pp. 17-26; vol. 20.
Anderson, “Strategies in the Design Solution-Stable, Water-Soluble Prodrugsii: Properties of Micellar Prodrugs of Methylprednisolone”;Journal of Pharmaceutical Sciences; 2006; pp. 375-381; vol. 74(4); Wiley-Liss
Di Mauro Thomas M.
Lilienfeld Sean
Codman & Shurtleff Inc.
DiMauro Thomas M. DiMauro M.
Witherspoon Sikarl
LandOfFree
Iontophoretic delivery of curcumin and curcumin analogs for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Iontophoretic delivery of curcumin and curcumin analogs for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Iontophoretic delivery of curcumin and curcumin analogs for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2693906